Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 15;113(3):622-5.
doi: 10.1182/blood-2008-03-139964. Epub 2008 Nov 20.

Impaired negative regulation of homeostatically proliferating T cells

Anna Shvets  1 , Rabindranath Chakrabarti, Rosana Gonzalez-Quintial, Roberto Baccala, Argyrios N Theofilopoulos, Gérald J Prud'homme
Affiliations

Impaired negative regulation of homeostatically proliferating T cells

Anna Shvets et al. Blood. .

Abstract

Acute lymphopenia-induced homeostatic proliferation (HP) of T cells promotes antitumor immunity, but the mechanism is unclear. We hypothesized that this is due to a lack of inhibitory signals that allows activation of T cells with low affinity for self-antigens. Tumors resist immunity in part by expressing inhibitory molecules such as PD-1 ligand 1 (PD-L1), B7-H4, and TGF-beta. In irradiated mice undergoing HP, we found that T cells displayed a severe deficit in the activation-induced expression of inhibitory molecules PD-1 and CTLA-4, and TGF-beta1-induced expression of Foxp3. HP T cells were also less suppressed by B7-H4/Ig and, unlike control T cells, failed to produce IL-10 in response to this molecule. This deficiency in regulation was reversed as normal T-cell numbers were restored. We conclude that T cells are weakly regulated by inhibitory molecules during the acute phase of HP, which could explain their increased effectiveness in cancer immunotherapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
T cells are defective in the expression of PD-1, CTLA-4, and Foxp3 at the early stages of HP. (A) Freshly isolated spleen cells were transfused into irradiated mice. After 2 weeks, splenic CD4+CD25− T cells were isolated and stimulated with anti-CD3/CD28 for 48 hours and analyzed for CD25 expression (IL-2α receptor). Almost all HP T cells were activated, as shown by up-regulation of CD25. Similar results were obtained with conventional (non-HP) T cells (data not shown). (B) Freshly isolated spleen cells were transfused into irradiated mice. After 2 weeks and 3 weeks, splenic CD4+CD25− T cells were isolated and stimulated with anti-CD3/CD28 for 48 hours and analyzed for PD-1 expression. Few HP T cells up-regulated PD-1 expression at 2 weeks, but this was restored to normal levels at 3 weeks. (C) Same as panel B, but analyzed for cytoplasmic and membrane CTLA-4. In panels A-C, dotted line histogram indicates isotype control; solid line histogram, specific antibody. Low expression of CTLA-4 followed the same pattern as PD-1 expression. (D) Same as panel B, but stimulation was in the absence (dotted line histogram) or presence (solid line histogram) of 2 ng/mL TGF-β1, and analyzed for Foxp3 expression. At 2 weeks, Foxp3 was poorly induced in HP T cells compared with control T cells, but this was restored at 3 weeks. (E) Percentage of Foxp3+ cells induced by TGF-β as in panel D (mean ± SEM; n = 4), at 2 weeks (HP 2 wk) or 3 weeks (HP 3 wk) after cell transfer. The expression of PD-1, CTLA-4, and Foxp3 was severely deficient at 2 weeks (n = 4, P < .05), but completely restored at 3 weeks. In all cases, 4 mice per group were examined and a representative histogram is shown.
Figure 2
Figure 2
HP T cells are weakly suppressed by CTLA-4 and B7-H4. (A) Splenic CD4+CD25− T cells recovered 2 or 3 weeks after cell transfer and stimulated with plate-bound anti-CD3/CD28, to induce CTLA-4 expression, and restimulated with anti-CD3 in the presence of anti–CTLA-4 (or control IgG). Supernatants were assayed for IFN-γ and IL-2. Results are presented as percentage suppression = 100 × (cytokine release in the absence of anti–CTLA-4 − cytokine release in the presence of anti-CTLA-4)/cytokine release in the absence of anti–CTLA-4. formula image indicates normal; □, HP 2 weeks; and ■, HP 3 weeks. Anti–CTLA-4 exerted significant inhibitory effect on normal and HP 3-week cells (P < .05). ** indicates IFNγ production was increased by 34% plus or minus 8%, rather than suppressed. (B-C) HP T cells (■) or control T cells (▲) were recovered 25 days following cell transfer and stimulated with anti-CD3/anti-CD28, in the presence or absence of B7-H4/Ig. Supernatants were assayed for IFNγ (B) and IL-2 (C). Similar results were obtained at 21 days after cell transfer (data not shown). * indicates HP T cells are significantly different from normal T cells (P < .05). (D) B7-H4/Ig costimulation enhances IL-10 production in normal (▲) but not HP T (■) cells (P < .05). The experimental protocol is same as panels B and C. The results are the mean plus or minus SEM of 3 mice.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dummer W, Niethammer AG, Baccala R, et al. T cell homeostatic proliferation elicits effective antitumor autoimmunity. J Clin Invest. 2002;10:185–192. - PMC - PubMed
    1. Baccala R, Gonzalez-Quintial R, Dummer W, et al. Tumor immunity via homeostatic T cell proliferation: mechanistic aspects and clinical perspectives. Springer Semin Immunopathol. 2005;27:75–85. - PubMed
    1. Williams KM, Hakim FT, Gress RE. T cell immune reconstitution following lymphodepletion. Semin Immunol. 2007;19:318–330. - PMC - PubMed
    1. Neujahr DC, Chen C, Huang X, et al. Accelerated memory cell homeostasis during T cell depletion and approaches to overcome it. J Immunol. 2006;176:4632–4639. - PubMed
    1. Borrello I, Sotomayor EM, Rattis FM, et al. Sustaining the graft-versus-tumor effect through posttransplant immunization with granulocyte-macrophage colony-stimulating factor (GM-CSF)-producing tumor vaccines. Blood. 2000;95:3011–3019. - PubMed

Publication types

MeSH terms